Indication : For the treatment of Type-2 Diabetes Mellitus.
Type 2 Diabetes mellitus a chronic condition that affects the way the body processes blood sugar.
MOA : Glimepiride stimulates insulin release from pancreatic beta cells by closing ATPsensitive potassium channels. Voglibose acts as an alpha-glucosidase inhibitor, used to treat type 2 diabetes by delaying carbohydrate digestion and absorption, thereby reducing postprandial blood glucose peaks. Metformin activates AMPK and reduce hepatic glucose levels.
